There is also an article describing a case of a particularly good response to treatment in a patient with metastatic gastric cancer with the PALB2 gene mutation [10]. This mutation is associated with homologous recombination deficiency and can lead to high sensitivity to platinum-based agents [10]. The gene discussed is PALB2; the disease is gastric cancer.